Can sermorelin improve your sleep?

How growth hormone and deep sleep are linked

In adults, the most reproducible growth hormone pulse of the day appears shortly after sleep begins, during the first stretch of slow-wave (deep) sleep. Reviews of the research describe a consistent relationship between deep sleep and growth hormone release.

Growth hormone-releasing hormone (GHRH), the signal that sermorelin mimics, appears to act as a common regulator of both the sleep EEG and nighttime hormone release. With age, deep sleep shortens, sleep becomes more broken, the nighttime cortisol rise comes earlier and growth hormone output is blunted.

What the GHRH studies found

Researchers have given GHRH to volunteers in sleep laboratories and measured sleep stages and hormones overnight. Earlier studies reported that GHRH given into the bloodstream improved aspects of sleep. A study of nasal GHRH in young and older people found effects on sleep stages as well.

A key finding for midlife and older adults: a 1997 clinical study reported that GHRH was less effective at modulating sleep and hormone activity in elderly people than in younger people. In other words, the age group most interested in this effect may respond least.

• These were small, short laboratory studies.
• They used injected or nasal GHRH, not a dissolving tablet.
• They measured sleep architecture, not how rested people felt over weeks or months.

What sermorelin can and cannot do for sleep

Some people taking sermorelin report deeper or more refreshing sleep. That is plausible given the biology, but it is not established, and placebo effects on sleep are strong. No large controlled trial has tested sermorelin for insomnia, and there are no published trials of sermorelin dissolving tablets for any sleep outcome. How well sermorelin is absorbed through the mouth has not been established.

Sermorelin does not treat the most common causes of poor sleep in midlife: obstructive sleep apnea, hot flashes and night sweats, anxiety or depression, an overactive thyroid, alcohol, pain, an irregular schedule or needing to urinate at night. Using it instead of addressing those can delay effective care.

Habits that protect deep sleep

• Keep a consistent sleep and wake time, including weekends.
• Limit alcohol, especially in the evening; heavy drinking disrupts both sleep and growth hormone patterns.
• Stop caffeine by early afternoon.
• Get daylight in the morning and keep the bedroom dark, quiet and cool.
• Exercise regularly, but finish vigorous sessions a few hours before bed.
• Avoid large meals late at night.

Why we look at your sleep before prescribing

Your HealifyMD clinician asks detailed questions about your sleep: snoring, gasping or witnessed pauses in breathing, daytime sleepiness, when you wake and why, hot flashes, mood, alcohol and caffeine. Sleep apnea in particular needs ruling out, because it is common, often missed and carries real heart and safety risks. If it seems likely, the next step is a sleep study, not a peptide.

Cognitive behavioral therapy for insomnia, menopause treatment when appropriate, treating sleep apnea and adjusting alcohol and evening habits have stronger evidence for better sleep than sermorelin does.

If you and your clinician decide to try it

• Keep a simple sleep diary for two weeks before starting and while on treatment, so you can judge change honestly.
• Expect your clinician to check IGF-1 at baseline and during treatment.
• Report new joint pain, swelling, numbness in the hands or headaches.
• Agree in advance how long you will try it and what would count as a meaningful improvement.
• Do not use it if you are pregnant or breastfeeding, have active cancer or have a pituitary tumor.

Regulatory status and cost

Sermorelin was previously FDA-approved as an injection (Geref) for children with growth hormone deficiency and for testing pituitary function. That product was discontinued in 2008, and the FDA later determined it was not withdrawn for safety or effectiveness reasons.

Sermorelin ODT through HealifyMD is compounded by a licensed U.S. pharmacy. It is not FDA-approved, has not been reviewed by the FDA for safety, effectiveness or quality and is not equivalent to the former branded injection. It is from $199/month, confirmed at the eligibility review, with labs priced separately.